What is Hylomorph?
HYLOMORPH AG is a clinical stage medical device company headquartered in Switzerland, focused on the development of advanced medical implants. The company's work is critical in advancing patient care through innovative technological solutions in the medical field. The recent major enterprise-level funding indicates a strong market belief in Hylomorph's potential to disrupt the medical device sector.
How much funding has Hylomorph raised?
Hylomorph has raised a total of $5M across 1 funding round:
Series B
$5M
Series B (2023): $5M with participation from Excellis Holding, StartAngels Network, and Verve Ventures
Key Investors in Hylomorph
Excellis Holding
Excellis Holding is an undisclosed investor participating in the funding round.
StartAngels Network
StartAngels Network is a platform for business angel investors, founded in 1999, that connects its members with attractive investment opportunities in early-stage companies in Switzerland. The network consists of approximately 85 business angel investors who provide direct support to startups through coaching and networking.
Verve Ventures
Verve Ventures is a network and technology-driven venture capital firm headquartered in Switzerland. Founded in 2010, Verve Ventures invests from EUR 500k to several million from Seed to Series B and beyond across Europe, focusing on digital, tangible, and health & bio startups.
What's next for Hylomorph?
With the recent major strategic investment, Hylomorph AG is poised for accelerated growth and development. This capital is expected to fuel further research and development, potentially leading to expanded clinical trials and the scaling of manufacturing capabilities. The company's focus on medical implants suggests a trajectory towards regulatory approvals and market penetration, aiming to establish itself as a leader in its specialized niche within the healthcare industry. Future endeavors will likely involve strategic partnerships and continued innovation to address unmet clinical needs.
See full Hylomorph company page
